Table 1 Clinical findings and response to treatment with oral valacyclovir
From: Valacyclovir in the treatment of acute retinal necrosis
Patient | Age,Sex | Eye | Virus | Posterior extent (zone) | Time to initial response (weeks) | Time to complete resolution (weeks) | Initial BCVA | Final BCVA | Laser | Steroids | Complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 79, M | R | Undetermined | 1 | 1 | 5 | 20/200 | 20/40 | No – Zone 1 | OFSI | RPE change at macula |
2 | 39, M | L | Presumed VZV | 3 | 1 | 1 | 20/20 | 20/20 | No – Zone 1 | No | Nil |
3 | 82, M | R | VZV on PCR | 1 | 1 | 4 | 20/120 | CFs | Yes | Oral prednisolone | RD at 45 days |
4 | 54, F | L | VZV on PCR | 2 | 2 | 6 | CFs | 20/60 | Yes | Oral prednisolone | Nil |
5 | 36, M | R | HSV-2 on PCR | 2 | 1 | 3 | 20/30 | 20/80 | Yes | Oral prednisolone | RD at 35 days |
6 | 36, M | L | Undetermined | 3 | 1 | 3 | 20/20 | 20/16 | No | No | Nil |
7 | 33, M | L | Presumed HSV-1 | 1 | 2 | 5 | HMs | LP | No – Zone 1 | Oral prednisolone | RD at 49 days |
8 | 30, F | R | Presumed VZV | 3 | 1 | 2 | 20/20 | 20/20 | Yes | No | Nil |
| Â | Â | L | Presumed VZV | 2 | 1 | 2 | 20/30 | 20/20 | Yes | No | Nil |
9 | 81, M | L | Undetermined | 2 | 1 | 6 | 20/20 | 20/40 | Yes | Oral prednisolone | Nil |